UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Eficacia y seguridad de un tratamiento oral a base de mucopolisacáridos, colágeno tipo i y vitamina C en pacientes con tendinopatías

Apunts : medicina de l'esport, 2014-04, Vol.49 (182), p.31-36

2014

Volltextzugriff (PDF)

The efficacy and safety of oral mucopolysaccharide, type I collagen and vitamin C treatment in tendinopathy patients

Apunts : medicina de l'esport, 2014, Vol.49 (182)

2014

Volltextzugriff (PDF)

A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition

Leukemia & lymphoma, 2024-03, Vol.65 (3), p.394-5

2024

Volltextzugriff (PDF)

Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan

Bone marrow transplantation (Basingstoke), 2022-08, Vol.57 (8), p.1304-1312

2022

Volltextzugriff (PDF)

Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

The Lancet (British edition), 2023-09, Vol.402 (10406), p.988-996

2023

Volltextzugriff (PDF)

Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis

Annals of hematology, 2019-10, Vol.98 (10), p.2319-2328

2019

Volltextzugriff (PDF)

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

BMC public health, 2022-07, Vol.22 (1), p.1385-10, Article 1385

2022

Volltextzugriff (PDF)

Predictors of outcomes after internal fixation of periprosthetic femoral hip fractures Subgroup analysis of the peri-implant and peri-prosthetic fractures Spanish registry (PIPPAS)

Injury, 2024-10, Vol.55 (10), p.111715, Article 111715

2024

Volltextzugriff (PDF)

Triple Negative Myelofibrosis and Myelodysplastic Syndrome with Fibrosis: Clinico-Biological Characterization and Correlation with Gene Mutations

Blood, 2018-11, Vol.132 (Supplement 1), p.4299-4299

2018

Volltextzugriff (PDF)

Ponatinib and Chemotherapy in Young Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblstic Leukemia. Preliminary Results of Ponalfil Clinical Trial

Blood, 2019-11, Vol.134 (Supplement_1), p.3874-3874

2019

Volltextzugriff (PDF)

Results of an International Survey on Feeding Management in Infants With Short Bowel Syndrome‐Associated Intestinal Failure

Journal of pediatric gastroenterology and nutrition, 2021-11, Vol.73 (5), p.647-653

2021

Volltextzugriff (PDF)

Outcomes after Plerixafor Plus FLAG-IDA (PLERIFLAG) Versus FLAG-IDA +/- Gentuzumab for Adult Patients with First Relapsed/Refractory AML: A Propensity Score Analysis from the Pethema Registry

Blood, 2019-11, Vol.134 (Supplement_1), p.1321-1321

2019

Volltextzugriff (PDF)

Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols

European journal of haematology, 2020-08, Vol.105 (2), p.138-147

2020

Volltextzugriff (PDF)

Optimizing periprosthetic fracture management and in-hospital outcome: insights from the PIPPAS multicentric study of 1387 cases in Spain

Journal of orthopaedics and traumatology, 2024-03, Vol.25 (1), p.13-13, Article 13

2024

Volltextzugriff (PDF)

Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin

Annals of hematology, 2017-07, Vol.96 (7), p.1077-1084

2017

Volltextzugriff (PDF)

Refractory nonconvulsive status epilepticus in Creutzfeldt-Jakob disease

Epileptic disorders, 2010-09, Vol.12 (3), p.239-242

2010

Volltextzugriff (PDF)

Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial

EClinicalMedicine, 2023-03, Vol.57, p.101898-101898, Article 101898

2023

Volltextzugriff (PDF)

Meningeal melanocytosis: a possibly useful treatment for a rare primary brain neoplasm

Journal of neurology, 2011-06, Vol.258 (6), p.1169-1171

2011

Volltextzugriff (PDF)

Scute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). study of 61 patients treated with intensive protocols

European journal of haematology, 2020-04

2020

Volltextzugriff (PDF)

The continuum of ovarian response leading to BIRTH, a real world study of ART in Spain

Fertility research and practice, 2020-07, Vol.6 (1), p.13-13, Article 13

2020

Volltextzugriff (PDF)

Modification of brain lipids but not phenotype in α-synucleinopathy transgenic mice by long-term dietary n-3 fatty acids

Neurochemistry international, 2010, Vol.56 (2), p.318-328

2010

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Eficacia y seguridad de un tratamiento oral a base de mucopolisacáridos, colágeno tipo i y vitamina C en pacientes con tendinopatías

Eficàcia i seguretat d’un tractament oral a base de mucopolisacàrids, col·lagen tipus I i vitamina C en pacients amb tendinopaties

The efficacy and safety of oral mucopolysaccharide, type I collagen and vitamin C treatment in tendinopathy patients

A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition

Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan

Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

Predictors of outcomes after internal fixation of periprosthetic femoral hip fractures Subgroup analysis of the peri-implant and peri-prosthetic fractures Spanish registry (PIPPAS)

Triple Negative Myelofibrosis and Myelodysplastic Syndrome with Fibrosis: Clinico-Biological Characterization and Correlation with Gene Mutations

A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

Ponatinib and Chemotherapy in Young Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblstic Leukemia. Preliminary Results of Ponalfil Clinical Trial

S132: UPDATED RESULTS OF VEN‐A‐QUI STUDY: A PHASE 1‐2 TRIAL TO ASSESS THE SAFETY AND EFFICACY OF TRIPLETS FOR NEWLY DIAGNOSED UNFIT AML PATIENTS: AZACITIDINE OR LOW‐DOSE CYTARABINE WITH VENETOCLAX AND QUIZARTINIB

Results of an International Survey on Feeding Management in Infants With Short Bowel Syndrome‐Associated Intestinal Failure

Outcomes after Plerixafor Plus FLAG-IDA (PLERIFLAG) Versus FLAG-IDA +/- Gentuzumab for Adult Patients with First Relapsed/Refractory AML: A Propensity Score Analysis from the Pethema Registry

Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols

Optimizing periprosthetic fracture management and in-hospital outcome: insights from the PIPPAS multicentric study of 1387 cases in Spain

Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin

Correction to: A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

Refractory nonconvulsive status epilepticus in Creutzfeldt-Jakob disease

Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial

Meningeal melanocytosis: a possibly useful treatment for a rare primary brain neoplasm

Scute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). study of 61 patients treated with intensive protocols

The continuum of ovarian response leading to BIRTH, a real world study of ART in Spain

Modification of brain lipids but not phenotype in α-synucleinopathy transgenic mice by long-term dietary n-3 fatty acids

Suchergebnisse filtern